Barbara E. Thalenfeld

Barbara E. Thalenfeld

Chief Tech/Sci/R&D Officer at Enzo Therapeutics, Inc.

84 year
Consumer Services
Health Technology
Commercial Services

Profile

Barbara E.
Thalenfeld
is Vice President of Corporate Development for Enzo Biochem, Inc. and Vice President of Clinical Affairs for Enzo Therapeutics.
She joined Enzo Biochem in 1982 and is a Member of the American Society of Gene Therapy, the Association of Clinical Research Professionals and the Drug Development Association.
Dr. Thalenfeld received a PhD at the Institute of Microbiology from Hebrew University and an MS in Molecular Biology from Yale University.
She completed a Post Doctoral Fellowship in the Department of Biological Sciences at Columbia University.

Barbara E. Thalenfeld active positions

CompaniesPositionStart
American Society of Gene Therapy Corporate Officer/Principal -
Corporate Officer/Principal -
Enzo Therapeutics, Inc. Chief Tech/Sci/R&D Officer -
International Assoc of Generic & Innovative Drug Manufacturer Corporate Officer/Principal -
All active positions of Barbara E. Thalenfeld

Former positions of Barbara E. Thalenfeld

Training of Barbara E. Thalenfeld

The Hebrew University of Jerusalem Doctorate Degree
Yale University Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Barbara E. Thalenfeld's experience

Connections

44

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
ENZO BIOCHEM, INC.

Health Technology

Private companies4
American Society of Gene Therapy

Commercial Services

Enzo Therapeutics, Inc.

International Assoc of Generic & Innovative Drug Manufacturer

See company connections
  1. Stock Market
  2. Insiders
  3. Barbara E. Thalenfeld